REGENXBIO Inc. (RGNX) REGENXBIO Inc. develops gene therapies to treat rare diseases and retinal disorders using its NAV Technology Platform. Its pipeline includes treatments for conditions like wet AMD and Duchenne muscular dystrophy, with partnerships fueling growth and innovation. Chart Nuvectis Pharma, Inc. (NVCT) Nuvectis Pharma focuses on oncology therapeutics targeting difficult-to-treat cancers. Its lead […]
Read MoreSoleno Therapeutics, Inc. (SLNO) Soleno Therapeutics focuses on developing treatments for rare diseases, notably Prader-Willi syndrome. The company’s lead candidate, DCCR, is advancing through late-stage clinical trials and represents a significant growth catalyst driven by unmet medical needs and regulatory progress. Chart CME Group Inc. (CME) CME Group operates one of the world’s largest derivatives […]
Read MorePhilip Morris International Inc (PM) Philip Morris International Inc is a leading global tobacco company known for its iconic Marlboro brand outside the U.S. The company is shifting focus from traditional cigarettes to reduced-risk products (RRPs), led by its IQOS heated tobacco system. PM aims to transition smokers to smoke-free alternatives by investing heavily in […]
Read MoreTootsie Roll Industries, Inc. (TR) Tootsie Roll Industries, Inc. manufactures and sells confectionery products including Tootsie Rolls, Tootsie Pops, and other iconic candies. Its stable brand recognition, seasonal sales cycles, and strategic distribution have supported steady growth. The company’s low-debt profile and global presence further enhance its resilience. Chart Inter & Co. Inc. (INTR) Inter […]
Read MoreVirtu Financial, Inc. (VIRT) Virtu Financial, Inc. is a global financial services firm that provides market-making and execution services. Known for its proprietary technology and high-frequency trading, the company benefits from market volatility and increased trading volume. Its consistent liquidity provisioning supports client growth. Chart Inter & Co. Inc. (INTR) Inter & Co. Inc. is […]
Read More